Artigo de periodico

RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients (2017)

• Authors:
  • Dezana, Marcia R.
  • Ribeiro, Ingrid Helena
  • Oliveira, Valéria B.
  • Vieira, Juliana B.
  • Gomes, Francisco C.
  • Franco, Lucas Augusto Moysés
  • Varuzza, Leonardo
  • Ribeiro, Roberto
  • Chinoca, Karen Ziza
  • Levi, José Eduardo
  • Krieger, Jose Eduardo
  • Pereira, Alexandre Costa
  • Gualandro, Sandra Fátima Menosi
  • Rocha, Vanderson Geraldo
  • Mendrone Júnior, Alfredo
  • Sabino, Ester Cerdeira
  • Dinardo, Carla Luana
• USP affiliated authors: KRIEGER, JOSE EDUARDO - FM ; GUALANDRO, SANDRA FATIMA MENOSI - FM ; ROCHA, VANDERSON GERALDO - FM ; SABINO, ESTER CERDEIRA - FM
• Unidade: FM
• DOI: 10.1016/j.bcmd.2017.03.014
• Subjects: GENÓTIPOS; TÉCNICAS CITOLÓGICAS; REAÇÃO EM CADEIA POR POLIMERASE; TRANSFUSÃO DE SANGUE; SEQUENCIAMENTO GENÉTICO
• Language: Inglês
• Imprenta:
  • Publisher place: California
  • Date published: 2017
• Source:
  • Título: Blood Cells, Molecules, and Diseases
  • ISSN: 1079-9796
  • Volume/Número/Paginação/Ano: v. 65, n. 1, p. 8-15, 2017


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui versão em acesso aberto em repositório (Green Open Access)

Versão do Documento:

Versão submetida (Pré-print)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  DEZANA, Marcia R. et al. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells, Molecules, and Diseases, v. 65, n. 1, p. 8-15, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2017.03.014. Acesso em: 15 abr. 2026.

• APA

  Dezana, M. R., Ribeiro, I. H., Oliveira, V. B., Vieira, J. B., Gomes, F. C., Franco, L. A. M., et al. (2017). RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells, Molecules, and Diseases, 65( 1), 8-15. doi:10.1016/j.bcmd.2017.03.014

• NLM

  Dezana MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone Júnior A, Sabino EC, Dinardo CL. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients [Internet]. Blood Cells, Molecules, and Diseases. 2017 ; 65( 1): 8-15.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2017.03.014

• Vancouver

  Dezana MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone Júnior A, Sabino EC, Dinardo CL. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients [Internet]. Blood Cells, Molecules, and Diseases. 2017 ; 65( 1): 8-15.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2017.03.014

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients
• Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity
• Effectiveness of strategies to screen for blood donors with RH variants in a mixed population
• SMIM1 intron 2 gene variations leading to variability in Vel antigen expression among Brazilian blood donors
• High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype
• Impact of HLA-G+3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease
• Massive autoimmune hemolysis documented by monocyte monolayer assay in a multiply transfused patient using reticulocytes isolated by simple centrifugation in microhematocrit tubes
• Risk factors for deferral due to low hematocrit and iron depletion among prospective blood donors in a Brazilian center
• Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort
• Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?